Finding. IL-1β tells colorectal cancer cells to ferment and to idle their mitochondria. Glycolysis goes up. Maximal mitochondrial respiration goes down. AKT is phosphorylated and HIF1α protein rises. Genetically, AKT1/2 sits above HIF1α: lose HIF1α and AKT still phosphorylates; lose AKT1/2 and HIF1α never rises and glycolysis never answers IL-1β. TNFα uses the same two proteins to raise glycolysis. The authors also frame IL-1β as suppressing oxidation of butyrate, the fiber-derived short-chain fatty acid colonocytes usually burn.
Why this paper matters
CRC literature is full of Warburg slogans. This paper names a cytokine that is already high in the disease, then orders the intracellular path with knockouts instead of inhibitor-only pharmacology. The mitochondrial sentence is not decorative: maximal respiration falls while glycolysis rises, which is a fuel-choice claim, not only a GLUT1 blot.
Butyrate is the local mitochondrial substrate that makes this a colon story rather than a generic HIF paper. If inflammation blocks butyrate oxidation, the fiber–mitochondria axis in the colon is part of the inflammatory metabolic program.
What they actually measured
IL-1β effects on glycolysis, maximal mitochondrial respiration, AKT phosphorylation, and HIF1α. AKT1/2 and HIF1α knockout lines to test necessity and order. TNFα as a second cytokine on the same AKT–HIF1α glycolytic path. Butyrate oxidation as a fiber-nutrient counterweight.
The abstract is stronger on glycolysis genetics than on the respiratory mechanism. “Inhibited maximal mitochondrial respiration” is one Seahorse number until the PDF shows substrates and leak.
How to read the score
Low-to-mid seventies. Clean genetic order, two cytokines, a mitochondrial respiration down-arrow. Confidence is medium. Cell-line, no in vivo. Score 73.
What to do with it
Track if you model CRC immunometabolism, HIF in inflammation, or colonocyte butyrate oxidation. Pull the OCR and butyrate assays and the AKT/HIF knockout controls. Do not treat IL-1 or HIF blockade as a metabolic CRC therapy from this brief. The directional implication is that inflammatory cytokines can impose a glycolytic, respiration-poor state through AKT-then-HIF1α.